Macrogenics Inc (NASDAQ:MGNX) shares traded -77.44% lower at $3.31 on Wall Street last session.
MGNX stock price is now -79.79% away from the 50-day moving average and -67.77% away from the 200-day moving average. The market capitalization of the company currently stands at $207.07M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
#####
On May 10, 2024, Stifel Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $29 to quote $7, while ‘BMO Capital Markets’ rates the stock as ‘Market Perform’
In other news, Peters Jeffrey Stuart, Senior VP and General Counsel sold 51,395 shares of the company’s stock on Apr 04 ’24. The stock was sold for $799,148 at an average price of $15.55. Upon completion of the transaction, the Senior VP and General Counsel now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 06 ’24, Senior VP and General Counsel Peters Jeffrey Stuart sold 19,625 shares of the business’s stock. A total of $421,938 was realized by selling the stock at an average price of $21.50. This leaves the insider owning 8,895 shares of the company worth $29442.45. A total of 6.45% of the company’s stock is owned by insiders.
During the past 12 months, Macrogenics Inc has had a low of $4.29 and a high of $21.88. As of last week, the company has a debt-to-equity ratio of 0.32, a current ratio of 3.63, and a quick ratio of 3.61.
According to the Biotechnology Company, earnings per share came in at 0.92, beating analysts’ expectations of -0.52 by 1.44. This compares to -$0.61 EPS in the same period last year. The net profit margin was -53.60% and return on equity was -21.58% for MGNX. The company reported revenue of $9.1 million for the quarter, compared to $24.5 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -62.83 percent. For the current quarter, analysts expect MGNX to generate $16.71M in revenue.
#####
#####